Loading...
A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
End of study analyses of the phase III trials of prophylactic human papillomavirus (HPV) virus-like particle (VLP) vaccines in young women are now largely completed. Two distinct vaccines were evaluated, Gardasil(®) (Merck & Co., Whitehouse Station, NJ USA) a quadrivalent vaccine containing VLPs...
Saved in:
| Published in: | Vaccine |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2012
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4636904/ https://ncbi.nlm.nih.gov/pubmed/23199956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2012.04.108 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|